臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"yeh k h"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 116-140 / 753 (共31頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-09-01T02:02:37Z	Inhibition of the membrane translocation and activation of protein kinase C, and potentiation of doxorubicin-induced apoptosis of hepatocellular carcinoma cells by tamoxifen	ANN-LII CHENG; Chuang S.-E.; Fine R.L.; Yeh K.-H.; Liao C.-M.; Lay J.-D.; Chen D.-S.
臺大學術典藏	2021-09-01T02:02:37Z	Biochemical modulation of doxorubicin by high-dose tamoxifen in the treatment of advanced hepatocellular carcinoma	ANN-LII CHENG; Yeh K.-H.; Fine R.L.; Chuang S.-E.; Yang C.-H.; Wang L.-H.; Chen D.-S.
臺大學術典藏	2021-09-01T02:02:36Z	High-dose therapy with peripheral blood stem cell (PBSC) support using an innovative mobilization regimen in patients with high-risk primary or chemoresponsive metastatic breast cancers	Yeh K.-H.; Lin M.-T.; Lin D.-T.; Tang J.-L.; Lui L.-T.; Lin J.-F.; Chang Y.-S.; ANN-LII CHENG; Yu S.-C.; Chang K.-J.; Chen Y.-C.
臺大學術典藏	2021-09-01T02:02:36Z	Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: A pilot study of the BOMES protocol	ANN-LII CHENG; Yeh K.-H.; Uen W.-C.; Hung R.-L.; Liu M.-Y.; Wang C.-H.
臺大學術典藏	2021-09-01T02:02:36Z	High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy	Yeh K.-H.; Shun C.-T.; Chen C.-L.; Lin J.-T.; Lee W.-J.; Lee P.-H.; Chen Y.-C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:35Z	Quiescent nasal T/NK cell lymphoma manifested as primary central nervous system lymphoma	Yeh K.-H.; Lien H.-C.; Hsu S.-M.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:34Z	High dose tamoxifen plus cisplatin and etoposide in the treatment of patients with advanced, inoperable nonsmall cell lung carcinoma	Yang C.-H.; ANN-LII CHENG; Yeh K.-H.; Yu C.-J.; Lin J.-F.; Yang P.-C.
臺大學術典藏	2021-09-01T02:02:34Z	Overexpression of p53 is not associated with drug resistance of gastric cancers to 5-fluorouracil-based systemic chemotherapy	Yeh K.-H.; Shun C.-T.; Chen C.-L.; Lin J.-T.; Lee W.-J.; Lee P.-H.; Chen Y.-C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:33Z	Prolonged and enhanced suppression of thymidylate synthase by weekly 24-h infusion of high-dose 5-fluorouracil	Yeh K.-H.; Yeh S.-H.; Hsu C.-H.; Wang T.-M.; Ma I.-F.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:33Z	Concurrent chemoradiotherapy for locally advanced esophageal cancer - A pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil	Hsu C.-H.; Yeh K.-H.; Lui L.T.; Lee Y.-C.; Bu C.-F.; Wang H.-P.; Lin J.-T.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:32Z	Minimal toxicity to myeloid progenitor cells of weekly 24-hr infusion of high-dose 5-fluorouracil: Direct evidence from colony forming unit- granulocyte and monocyte (CFU-GM) clonogenic assay	Yeh K.-H.; Yeh S.-H.; Chang Y.-S.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:31Z	Nuclear extracellular signal-regulated kinase 2 phosphorylates p53 at Thr55 in response to doxorubicin	Yeh P.Y.; Chuang S.-E.; Yeh K.-H.; Chyi Song Y.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:29Z	Combination of 13-cis retinoic acid and interferon-α in the treatment of recurrent or refractory peripheral T-cell lymphoma	Huang C.-L.; Lin Z.-Z.; Su I.-J.; Chao T.-Y.; Tien H.-F.; Chang M.-C.; Huang M.-C.; Kao W.-Y.; Tang J.-L.; Yeh K.-H.; Wang C.-H.; Hsu C.-H.; Liu M.-Y.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:28Z	P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection	Liang J.-T.; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; ANN-LII CHENG; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Chang K.-J.
臺大學術典藏	2021-09-01T02:02:27Z	Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NFκB activation	Yeh P.Y.; Chuang S.-E.; Yeh K.-H.; Song Y.C.; Ea C.-K.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:27Z	High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection	Liang J.-T.; Huang K.-C.; Lai H.-S.; Lee P.-H.; Cheng Y.-M.; Hsu H.-C.; ANN-LII CHENG; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Tang C.; Chang K.-J.
臺大學術典藏	2021-09-01T02:02:26Z	A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil	Hsu C.-H.; ANN-LII CHENG; Hsu C.; Yang C.-H.; Lu Y.-S.; Lin C.-C.; Bu C.-F.; Yeh K.-H.
臺大學術典藏	2021-09-01T02:02:24Z	Involvement of nuclear transcription factor-κB in low-dose doxorubicin-induced drug resistance of cervical carcinoma cells	Yeh P.Y.; Chuang S.-E.; Yeh K.-H.; Song Y.C.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:22Z	Recent advances in therapy for gastric cancer	Yeh K.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:22Z	Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cells	Yeh K.-H.; ANN-LII CHENG; Wan J.-P.; Lin C.-S.; Liu C.-C.
臺大學術典藏	2021-09-01T02:02:22Z	High-dose Tamoxifen Modulates Drug Resistance to Doxorubicin, Dacarbazine and Ifosfamide in Metastatic Uterine Leiomyosarcoma	Yeh K.-H.; Lu Y.-S.; Hsiao C.-H.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:21Z	Weekly gemcitabine plus 24-h infusion of high-dose 5-fluorouracil/ leucovorin for locally advanced or metastatic carcinoma of the biliary tract	Hsu C.; Shen Y.-C.; Yang C.-H.; Yeh K.-H.; Lu Y.-S.; Hsu C.-H.; Liu H.-T.; Li C.-C.; Chen J.-S.; Wu C.-Y.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:21Z	Phase II study of combination doxorubicin, interferon-α, and high-dose tamoxifen treatment for advanced hepatocellular carcinoma	Lu Y.-S.; Hsu C.; Li C.-C.; Kuo S.-H.; Yeh K.-H.; Yang C.-H.; Hsu C.-H.; Wu C.-Y.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:21Z	Phosphorylation of p53 on Thr55 by ERK2 is necessary for doxorubicin-induced p53 activation and cell death	Yeh P.Y.; Chuang S.-E.; Yeh K.-H.; Song Y.C.; Chang L.L.-Y.; ANN-LII CHENG
臺大學術典藏	2021-09-01T02:02:20Z	Suppression of MEK/ERK signaling pathway enhances cisplatin-induced NF-κB activation by protein phosphatase 4-mediated NF-κB p 65 Thr dephosphorylation	Yeh P.Y.; Yeh K.-H.; Chuang S.-E.; Song Y.C.; ANN-LII CHENG

顯示項目 116-140 / 753 (共31頁)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 52730808 線上人數 : 538 教育部委託研究計畫計畫執行:國立臺灣大學圖書館